Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Montano

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Haematologica|January 25, 2012
ETV6-PDGFRB and FIP1L1-PDGFRA stimulate human hematopoietic progenitor cell proliferation and differentiation into eosinophils: the role of nuclear factor-κBCarmen P Montano-Almendras, Ahmed Essaghir, Hélène Schoemans, et al.
Oncogene|June 12, 2013
PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutationsA I Velghe, S Van Cauwenberghe, A A Polyansky, et al.
Molecular Oncology|March 13, 2014
The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1-PDGFRα and PDGFRα D842VLaura A Noël, Florence A Arts, Carmen P Montano-Almendras, et al.
Revista Cubana De Medicina Tropical|June 1, 1999
[The research and work of the Instituto de Neurología y Neurocirugía on epidemic neuropathy from the 1st workshop in 1994 up to the date of the 2nd workshop in 1998]S L González, R Santiesteban Freixas, A González-Quevedo, et al.
Blood|August 19, 2017
<i>TP53</i> mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapyChristian W Eskelund, Christina Dahl, Jakob W Hansen, et al.
British Journal of Haematology|November 5, 2011
PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignanciesFrancois P Duhoux, Geneviève Ameye, Carmen P Montano-Almendras, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Haematologica|January 25, 2012
ETV6-PDGFRB and FIP1L1-PDGFRA stimulate human hematopoietic progenitor cell proliferation and differentiation into eosinophils: the role of nuclear factor-κBCarmen P Montano-Almendras, Ahmed Essaghir, Hélène Schoemans, et al.
Oncogene|June 12, 2013
PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutationsA I Velghe, S Van Cauwenberghe, A A Polyansky, et al.
Molecular Oncology|March 13, 2014
The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1-PDGFRα and PDGFRα D842VLaura A Noël, Florence A Arts, Carmen P Montano-Almendras, et al.
Revista Cubana De Medicina Tropical|June 1, 1999
[The research and work of the Instituto de Neurología y Neurocirugía on epidemic neuropathy from the 1st workshop in 1994 up to the date of the 2nd workshop in 1998]S L González, R Santiesteban Freixas, A González-Quevedo, et al.
Blood|August 19, 2017
<i>TP53</i> mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapyChristian W Eskelund, Christina Dahl, Jakob W Hansen, et al.
British Journal of Haematology|November 5, 2011
PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignanciesFrancois P Duhoux, Geneviève Ameye, Carmen P Montano-Almendras, et al.
Pageof 2